-+ 0.00%
-+ 0.00%
-+ 0.00%

OS Therapies names Kerry Clem chief commercial officer

PUBT·10/01/2026 12:33:15
Listen to the news
OS Therapies names Kerry Clem chief commercial officer
  • OS Therapies appointed Kerry Clem as chief commercial officer to lead U.S., U.K., and European launch planning for Herlystic.
  • Clem previously served as CEO of Solaxa, was CCO at Acorda Therapeutics, held commercial roles at Allos Therapeutics.
  • Frank Knuettel II was named chief financial officer as OS Therapies prepares to shift from development-stage to commercialization.
  • Knuettel was CFO of Pelthos Therapeutics, was CEO of Channel Therapeutics, led more than 15 M&A deals.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610010830NEWSFILECNPR____20261001_316882_1) on October 01, 2026, and is solely responsible for the information contained therein.